Geneos Wealth Management’s FT Vest U.S. Equity Max Buffer ETF - October OCTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$363K Hold
10,600
– – 0.01% 886
2026
Q2
$356K Buy
10,600
+2,000
+23% +$66.6K 0.01% 823
2026
Q1
$280K Hold
8,600
– – 0.01% 860
2025
Q4
$281K Hold
8,600
– – 0.01% 820
2025
Q3
$277K Hold
8,600
– – 0.01% 811
2025
Q2
$270K Buy
8,600
+3,300
+62% +$101K 0.01% 894
2025
Q1
$161K Hold
5,300
– – 0.01% 996
2024
Q4
$162K Buy
+5,300
New +$162K 0.01% 916

Other funds holding OCTM

Geneos Wealth Management's OCTM Position: Q3 2026 in Review

Geneos Wealth Management held its FT Vest U.S. Equity Max Buffer ETF - October (OCTM) position steady in Q3 2026 at 10,600 shares worth $363K. The position accounts for 0.01% of the portfolio, ranked #886.

Geneos Wealth Management first reported a position in OCTM in Q4 2024 and has held it in 8 quarters since. 40 funds tracked by Wall St. Rank hold OCTM as of Q3 2026.

  • Geneos Wealth Management held 10,600 shares of FT Vest U.S. Equity Max Buffer ETF - October worth $363K as of Q3 2026.
  • Geneos Wealth Management left its FT Vest U.S. Equity Max Buffer ETF - October share count unchanged in Q3 2026.
  • FT Vest U.S. Equity Max Buffer ETF - October made up 0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #886 holding.
  • Geneos Wealth Management first reported a position in FT Vest U.S. Equity Max Buffer ETF - October in Q4 2024 and has held it in 8 quarters since.
  • 40 funds tracked by Wall St. Rank held FT Vest U.S. Equity Max Buffer ETF - October as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.